Core Insights - Urban Outfitters (URBN) reported quarterly earnings of $1.28 per share, exceeding the Zacks Consensus Estimate of $1.19 per share, and showing an increase from $1.1 per share a year ago, resulting in an earnings surprise of +7.56% [1] - The company achieved revenues of $1.53 billion for the quarter ended October 2025, surpassing the Zacks Consensus Estimate by 2.43% and up from $1.36 billion year-over-year [2] - Urban Outfitters has consistently surpassed consensus EPS and revenue estimates over the last four quarters [2] Earnings Performance - The earnings surprise for the previous quarter was +9.72%, with actual earnings of $1.58 per share compared to an expected $1.44 per share [1] - The current consensus EPS estimate for the upcoming quarter is $1.34, with projected revenues of $1.77 billion, and for the current fiscal year, the EPS estimate is $5.24 on revenues of $6.1 billion [7] Stock Performance and Outlook - Urban Outfitters shares have increased by approximately 13.4% since the beginning of the year, compared to a 14% gain in the S&P 500 [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] - The outlook for the industry, particularly the Retail - Apparel and Shoes sector, is favorable, ranking in the top 24% of over 250 Zacks industries [8]

Core Viewpoint - Adma Biologics has been upgraded to a Zacks Rank 2 (Buy) due to an upward trend in earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Movement - The Zacks rating system is based on changes in earnings estimates, which are closely correlated with near-term stock price movements [4][6]. - Rising earnings estimates for Adma Biologics indicate an improvement in the company's underlying business, suggesting potential for stock price appreciation [5][8]. Zacks Rating System - The Zacks Rank stock-rating system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have averaged a +25% annual return since 1988 [7][9]. - Adma Biologics' upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [10]. Recent Earnings Estimate Revisions - For the fiscal year ending December 2025, Adma Biologics is expected to earn $0.58 per share, unchanged from the previous year, but the Zacks Consensus Estimate has increased by 1.6% over the past three months [8].

Core Insights - Broadcom Inc. (AVGO) shares increased by 11.1% to close at $377.96, following a notable trading volume, contrasting with a 3.9% loss over the past four weeks [1] - The company is benefiting from strong momentum driven by growth in AI semiconductors and successful VMware integration [1] Earnings Expectations - Broadcom is projected to report quarterly earnings of $1.87 per share, reflecting a year-over-year increase of 31.7% [2] - Expected revenues are $17.5 billion, which is a 24.5% increase compared to the same quarter last year [2] - Trends in earnings estimate revisions are correlated with near-term stock price movements, indicating potential strength in the stock [2] Stock Performance and Rankings - The consensus EPS estimate for Broadcom has remained unchanged over the last 30 days, suggesting that the stock's price may not continue to rise without earnings estimate revisions [3] - Broadcom currently holds a Zacks Rank of 3 (Hold) [3] - In the same industry, Marvell Technology (MRVL) saw an 8.2% increase in its stock price, closing at $83.79, despite a -7.9% return over the past month [3] Marvell Technology Insights - Marvell's consensus EPS estimate for the upcoming report is $0.75, representing a year-over-year change of 74.4% [4] - Marvell also holds a Zacks Rank of 3 (Hold) [4]

Core Insights - Abercrombie & Fitch reported quarterly earnings of $2.36 per share, exceeding the Zacks Consensus Estimate of $2.14 per share, but down from $2.50 per share a year ago, resulting in an earnings surprise of +10.28% [1][2] - The company achieved revenues of $1.29 billion for the quarter ended October 2025, surpassing the Zacks Consensus Estimate by 1.26% and up from $1.21 billion year-over-year [2] - Abercrombie has consistently surpassed consensus EPS and revenue estimates over the last four quarters [2] Earnings Outlook - The sustainability of Abercrombie's stock price movement will depend on management's commentary during the earnings call and future earnings expectations [3][4] - The current consensus EPS estimate for the upcoming quarter is $3.55 on revenues of $1.66 billion, and for the current fiscal year, it is $9.63 on revenues of $5.25 billion [7] Industry Context - The Retail - Apparel and Shoes industry, to which Abercrombie belongs, is currently ranked in the top 24% of over 250 Zacks industries, indicating a favorable outlook compared to lower-ranked industries [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Abercrombie's stock performance [5][6]

Core Insights - Kohl's reported quarterly earnings of $0.1 per share, exceeding the Zacks Consensus Estimate of a loss of $0.19 per share, and down from earnings of $0.2 per share a year ago, representing an earnings surprise of +152.63% [1] - The company posted revenues of $3.58 billion for the quarter ended October 2025, surpassing the Zacks Consensus Estimate by 2.55%, but down from $3.71 billion in the same quarter last year [2] - Kohl's has consistently surpassed consensus EPS estimates over the last four quarters, indicating strong performance [2] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.42 on revenues of $5.07 billion, and for the current fiscal year, it is $0.68 on revenues of $15.34 billion [7] - The trend of estimate revisions for Kohl's was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold), suggesting the stock is expected to perform in line with the market in the near future [6] Industry Context - The Retail - Regional Department Stores industry, to which Kohl's belongs, is currently ranked in the top 14% of over 250 Zacks industries, indicating a favorable outlook compared to lower-ranked industries [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Core Viewpoint - La-Z-Boy is recognized as a fundamentally strong consumer company, showing resilience in a challenging retail environment and is currently rated as a Zacks Rank 1 (Strong Buy) [1][2]. Financial Performance - Analysts have increased earnings estimates for La-Z-Boy, with the current year’s estimate rising from $2.86 to $2.95 and next year’s from $2.75 to $2.93, indicating confidence in the company's ability to improve margins [3]. - La-Z-Boy trades at a price-to-earnings ratio of 12.79x, while consistently beating earnings expectations and expanding gross margins [4]. Market Position - The company has effectively managed its supply chain and focused on higher-margin custom orders, maintaining demand for upholstery and custom furniture despite broader market concerns [2][3]. - La-Z-Boy benefits from a strong balance sheet and a loyal customer base that spans generations, positioning it well for future growth as consumer confidence improves [5].

Core Insights - Amentum Holdings reported quarterly earnings of $0.63 per share, exceeding the Zacks Consensus Estimate of $0.59 per share, and showing an increase from $0.47 per share a year ago, resulting in an earnings surprise of +6.78% [1][2] - The company achieved revenues of $3.93 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 8.81%, compared to $2.21 billion in the same quarter last year [2] - Amentum has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] Earnings Outlook - The sustainability of Amentum's stock price movement will largely depend on management's commentary during the earnings call and future earnings expectations [3][4] - The current consensus EPS estimate for the upcoming quarter is $0.55 on revenues of $3.4 billion, and for the current fiscal year, it is $2.39 on revenues of $14.05 billion [7] Industry Context - Amentum operates within the Zacks Engineering - R and D Services industry, which is currently ranked in the bottom 37% of over 250 Zacks industries, indicating potential challenges ahead [8] - The performance of Amentum's stock may be influenced by the overall outlook for the industry, as historical data shows that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]

Core Viewpoint - Maximus (MMS) has received an upgrade to a Zacks Rank 2 (Buy), indicating a positive outlook driven by rising earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates and Stock Performance - The Zacks rating system emphasizes the importance of earnings estimate revisions, which are strongly correlated with near-term stock price movements [4][6]. - For Maximus, the recent increase in earnings estimates suggests an improvement in the company's underlying business, likely leading to higher stock prices [5]. Zacks Rating System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 (Strong Buy) stocks historically generating an average annual return of +25% since 1988 [7]. - The upgrade of Maximus to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [10]. Earnings Estimate Revisions for Maximus - Maximus is projected to earn $7.34 per share for the fiscal year ending September 2026, reflecting no year-over-year change [8]. - Over the past three months, the Zacks Consensus Estimate for Maximus has increased by 20.5%, highlighting a positive trend in earnings expectations [8].

Core Viewpoint - Palomar (PLMR) has reached a significant support level and shows potential for investors from a technical perspective, particularly after breaking through the 20-day moving average, indicating a short-term bullish trend [1]. Technical Analysis - The 20-day simple moving average (SMA) is a widely used trading tool that smooths out price fluctuations over a 20-day period, providing more trend reversal signals than longer-term moving averages [1][2]. - A stock price above the 20-day SMA indicates a positive trend, while a price below suggests a downward trend [2]. Earnings Estimates - PLMR has experienced positive earnings estimate revisions, with no estimates decreasing in the past two months and five estimates increasing, leading to a rise in the consensus estimate [3]. - The combination of positive technical factors and favorable earnings estimate revisions suggests that investors may want to monitor PLMR for potential gains in the near future [3]. Performance Metrics - Over the past four weeks, PLMR has gained 8.4%, and the company holds a Zacks Rank 2 (Buy), indicating strong potential for further upward movement [4].

Core Insights - Skillsoft Corp. (SKIL) shares increased by 17.9% to close at $10.82, following a notable trading volume, despite a 46.3% loss over the past four weeks [1] - The company's Percipio platform has driven significant growth, with a 50% year-over-year increase in technology learners, 74% growth in AI learners, and a 158% rise in AI learning hours in Q2 of fiscal 2026 [2] - Skillsoft is projected to report quarterly earnings of $1.26 per share, reflecting a year-over-year increase of 169.2%, while revenues are expected to be $131.56 million, down 4.1% from the previous year [2] Earnings and Estimates - The consensus EPS estimate for Skillsoft has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [4] - The stock currently holds a Zacks Rank 1 (Strong Buy), indicating strong market confidence [5] Industry Context - Skillsoft operates within the Zacks Technology Services industry, where another company, Richtech (RR), has seen a decline of 43.9% over the past month, closing at $3 [5] - Richtech's consensus EPS estimate for its upcoming report is -$0.03, which is a 40% improvement from the previous year, and it currently holds a Zacks Rank of 3 (Hold) [6]